mRNA |
prima-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.3 |
mRNA |
hyperforin |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.3 |
mRNA |
Bosutinib |
CTRPv2 |
pan-cancer |
AAC |
0.04 |
0.3 |
mRNA |
LRRK2-IN-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.3 |
mRNA |
JNJ-26854165 |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.3 |
mRNA |
BRD-K03911514 |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.3 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.3 |
mRNA |
BRD-K97651142 |
CTRPv2 |
pan-cancer |
AAC |
0.042 |
0.3 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.3 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
0.041 |
0.3 |